Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

As society battles with an obesity epidemic, new research from the Edwards Group (Nuffield Department of Surgical Sciences / Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences) shows how increased body fat contributes to cancer establishment and progression.

Mouse bone marrow adipocytes stained with bodipy, a fluorescent dye that is taken up by lipid droplets
Mouse bone marrow adipocytes stained with bodipy, a fluorescent dye that is taken up by lipid droplets

Multiple myeloma is an incurable haematological cancer associated with the expansion of abnormal plasma cells within the bone marrow and the development of destructive bone disease. In the last couple of decades, bone marrow fat cells (adipocytes) have emerged as having an important role in bone physiology in health and disease.

Research from Professor Claire Edwards’ team at the Botnar Research Centre and published in the Journal of Bone and Mineral Research, identifies a new mechanism by which myeloma cells alter the bone microenvironment to support disease progression. 

Read more (Nuffield Department of Surgical Sciences website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.